Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-115693

Options or other derivatives

  • Chief Financial Officer acquired 33,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Prasad Raju Chief Financial Officer 2024-10-16 Grant or award · Stock Option (Right to Buy) +18,333 18,333 D: show line 1 in the form
Prasad Raju Chief Financial Officer 2024-10-16 Grant or award · Restricted Stock Units +15,000 15,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…